Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

NFκB Polymorphisms and susceptibility to type 1 diabetes

Genes & Immunity volume 2, pages 304–308 (2001)Cite this article

Abstract

Nuclear factor kappa B (NFκB) is an important transcription factor that is involved in the response to oxidative stress and inflammation. Recent studies suggest that it may be involved in the development of diabetic microvascular complications. A highly polymorphic (CA) dinucleotide repeat microsatellite has been identified in the regulatory region of the NFκB gene. The aim of this study was to investigate whether this polymorphic region was associated with susceptibility to type 1 diabetes, or its late complications. Genomic DNA was extracted from the peripheral blood of 217 patients with type 1 diabetes mellitus (T1DM) and 111 normal healthy controls. In our population 18 alleles (A1-A18) were identified. There was a highly significant decrease in the frequency of allele 146 bp (A14) in type 1 diabetes (0.03) compared with the normal controls (0.28) (χ2 = 79.8, Pc = 0.00001). In contrast, the frequency of the allele 138 bp (A10) was significantly increased in patients with type 1 diabetes (0.17) compared with the normal controls (0.02) (χ2 = 32.8, P < 0.00000). These results demonstrate that the NFκB gene may play a role in the susceptibility to type 1 diabetes: individuals with the A10 allele may be more likely to develop diabetes compared with the A14 allele.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Platz P, Jakobsen BK, Morling N et al HLA-D and DR antigens in genetic analysis of insulin-dependent diabetes mellitus Diabetologia 1981 21 108–115

    Article  CAS  Google Scholar 

  2. Wolf E, Spencer KM, Cudworth AG The genetic susceptibility to type 1 diabetes: analysis of the HLA-DR association Diabetologia 1983 24 224–230

    Article  CAS  Google Scholar 

  3. Todd JA Genetic analyses of type 1 diabetes using whole genome approaches Proc Natl Acad Sci 1995 92 8560–8565

    Article  CAS  Google Scholar 

  4. Hashimoto L, Habita C, Beressi JP et al Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q Nature 1994 371 161–164

    Article  CAS  Google Scholar 

  5. Merriman TR, Todd JA Genetics of insulin-dependent diabetes: non-major histocompatibility genes Horm Metab Res 1996 28 289–293

    Article  CAS  Google Scholar 

  6. Field LL, Tobias R Unravelling a complex trait: the genetics of insulin-dependent diabetes mellitus Clin Invest Med 1997 20 41–49

    CAS  PubMed  Google Scholar 

  7. Sen R, Baltimore D Multiple nuclear factors interact with the immunoglobulin enhancer sequences Cell 1986 46 705–716

    Article  CAS  Google Scholar 

  8. Le Beau MM, Ito C, Cogswell P, Espinosa R 3d, Fernald AA, Baldwin AS Jr Chromosomal localisation of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively Genomics 1992 14 529–531

    Article  CAS  Google Scholar 

  9. Brand K, Page S, Rogler G et al Activated transcription factor nuclear factor-kappa B is present in the artherosclerotic lesion J Clin Invest 1996 97 1715–1722

    Article  CAS  Google Scholar 

  10. Baeuerle PA The inducible transcription factor NF-κB: regulation by distinct protein subunits Biochim Biophys Acta 1991 1072 63–80

    CAS  PubMed  Google Scholar 

  11. Baeuerle PA, Baltimore D NF-κB: ten years after Cell 1996 87 13–20

    Article  CAS  Google Scholar 

  12. Barnes PJ, Karin M Nuclear factor κB – a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 1997 336 1066–1071

    Article  CAS  Google Scholar 

  13. Du X, Stockklauser-Farber K, Rosen P Generation of reactive oxygen intermediates, activation of NF-κB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase Free Radic Biol Med 1999 27 752–763

    Article  CAS  Google Scholar 

  14. The Diabetes Control and Complications Trial Research group The effect of intensive treatment of diabetes on the development and progression of long -term complications in insulin dependent diabetes mellitus N Engl J Med 1993 329 977–986

    Article  Google Scholar 

  15. Greene D, Lattimer SA, Sima AAF Sorbitol, phospho-inositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications N Engl J Med 1987 316 599–606

    Article  CAS  Google Scholar 

  16. Williamson JR, Chang K, Frangos M et al Hyperglycaemic pseudohypoxia and diabetic complications Diabetes 1993 42 801–813

    Article  CAS  Google Scholar 

  17. Friedman EA Advanced glycosylated end products and hyperglycaemia in the pathogenesis of diabetic complications Diabetes Care 1999 22 65–71

    Article  Google Scholar 

  18. Ceriello A Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications Diabetes Nutr Metab 1999 12 42–46

    CAS  PubMed  Google Scholar 

  19. Mohamed AK, Bierhaus A, Schiekofer S et al The role of oxidative stress and NF-Kappa B activation in late diabetic complications Biofactors 1999 10 157–167

    Article  CAS  Google Scholar 

  20. Hoffmann MA, Schiekofer S, Isermann B et al Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increase activation of the oxidative-stress sensitive transcription factor NF-κB Diabetologia 1999 42 222–232

    Article  Google Scholar 

  21. Yerneni KKV, Bai W, Khan BV, Medford RM, Natarjan R Hyperglycaemia-induced activation of nuclear transcription factor κB in vascular smooth muscle cells Diabetes 1999 48 855–864

    Article  CAS  Google Scholar 

  22. Quehenberger PB Endothelin-1 transcription is controlled by Nuclear Factor-κB in AGE-stimulated cultured endothelial cells Diabetes 2000 49 1561–1570

    Article  CAS  Google Scholar 

  23. Ota N, Nakajima T, Shirai Y, Emi M Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus J Hum Genet 1999 44 129–130

    Article  CAS  Google Scholar 

  24. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson I In vitro production of IFN gamma correlates with CA repeat polymorphism in the human IFN gamma gene Europe J Immunogenet 1999 26 1–3

    Article  CAS  Google Scholar 

  25. Fishman D, Faulds G, Jeffery R et al The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 1998 7 1369–1376

    Article  Google Scholar 

  26. Rim JS, Atta MG, Dahl SC et al Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region J Biol Chem 1998 273 20615–20621

    Article  CAS  Google Scholar 

  27. Heesom AE, Millward BA, Demaine AG Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′-end of the aldose reductase gene J Neurol Neurosurg Psy 1998 64 213–216

    Article  CAS  Google Scholar 

  28. Tiwari JL, Terasaki PI The data and statistical analysis. In: HLA and Disease Associations Springer-Verlag: New York 1985 pp 18–27

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Medicine, Postgraduate Medical School, University of Plymouth, Plymouth, PL6 8BX, UK

    DM Hegazy, DA O’Reilly, BM Yang, AD Hodgkinson, BA Millward & AG Demaine

Authors
  1. DM Hegazy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. DA O’Reilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. BM Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. AD Hodgkinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. BA Millward
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. AG Demaine
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to AG Demaine.

Additional information

This work was partly funded by grants from Diabetes UK.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hegazy, D., O’Reilly, D., Yang, B. et al. NFκB Polymorphisms and susceptibility to type 1 diabetes . Genes Immun 2, 304–308 (2001). https://doi.org/10.1038/sj.gene.6363776

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6363776

Keywords

This article is cited by

Search

Advanced search

Quick links